| Quarterly Financials | Mar 2025 | Jun 2025 |
Revenue  | 265 | 117 |
| Expenses | 265 | 112 |
| EBITDA | 0 | 5 |
| Operating Profit % | -0 % | 2 % |
| Depreciation | 0 | 0 |
| Interest | 2 | -0 |
| Profit Before Tax | -1 | 6 |
| Tax | 1 | 1 |
| Net Profit | -2 | 5 |
| EPS in ₹ | -0.05 | 0.05 |
Remedium Lifecare
Remedium Lifecare
1.57
+0.07
(4.67%)
Key Fundamentals
Market Cap
136.70 Cr
EPS
0.05
PE Ratio
77.50
Dividend Yield
0.00 %
Industry
Commercial Services 52 Week High
4.74
52 Week Low
0.80
PB Ratio
1.49
Debt to Equity
26.01
Sector
Trading & Distributors Actual
Company News
View All News
Remedium Lifecare Schedules Board Meeting to Consider Name Change and Capital Raising OptionsSep 16, 2025
Remedium Lifecare Limited has scheduled a Board of Directors meeting for September 22, 2025 to consider three key proposals: changing the company name, increasing authorized share capital with consequential amendments to the Memorandum of Association, and discussing capital raising options including Qualified Institutions Placement (QIP) or Rights Issue. All proposals are subject to necessary approvals from shareholders and regulatory authorities.
Remedium Lifecare Unveils 4-Point Strategy Targeting 4X Growth After Strong Q1 Performance
Aug 25, 2025
Aug 25, 2025Remedium Lifecare Ltd. announced a strategic roadmap based on four pillars to achieve 4X growth. The strategy focuses on advanced manufacturing through upgraded CDMO facilities and backward integration, global export expansion into new geographies, innovation and R&D excellence with a dedicated quality control laboratory covering anti-infectives, cardiovascular, and CNS treatments, and product diversification across specialty chemicals and pharmaceuticals. The company reported strong quarterly results with PAT of ₹464.88 lakh, a 327% surge from the previous quarter's loss of ₹204.60 lakh. EBITDA jumped 508%, and the single-quarter performance doubled the entire previous year's PAT of ₹212.94 lakh. The company successfully completed an oversubscribed Rights Issue, raising ₹47.88 crore against applications of ₹51.86 crore. Managing Director Adarsh Munjal stated that the quarterly PAT surpassed their entire previous year's profit, demonstrating operational agility and business model strength.
Remedium Lifecare Shareholders Approve Appointment of Two Independent Directors Through Postal BallotAug 13, 2025
Remedium Lifecare Ltd declared the results of a postal ballot on August 13, 2025, seeking shareholder approval for appointing two non-executive independent directors. The postal ballot notice was dated June 30, 2025, with remote e-voting conducted from July 14 to August 12, 2025. Both resolutions were passed with requisite majority. The appointment of Mr. Bikram Kumar Mund (DIN: 06919513) as non-executive independent director received 93.238% votes in favor from 5,009,416 valid votes cast. The appointment of Mr. Vijay Pal Singh Gulya (DIN: 01433784) as non-executive independent director received 92.737% votes in favor from 5,002,428 valid votes cast. Ms. Riddhi Shah served as the scrutinizer for the postal ballot process, and the results were declared by Whole Time Director Adarsh Munjal at the company's registered office.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
156.25 | #1 24,976.60 | 355.11 | 551.40 | 55,040.00 | 70 | 72.10 | 39.07 | |
264.05 | 20,642.80 | 11.24 | #1 99,561.70 | 11.11 | #1 1,821 | 7.37 | 45.39 | |
67.38 | 10,107.00 | 103.69 | 262.80 | 28.63 | 87 | 35.47 | 48.75 | |
533.40 | 3,755.10 | #1 8.83 | 387.50 | -25.38 | 407 | 7.63 | 53.26 | |
382.30 | 3,737.90 | 85.53 | 299.41 | #1 8,85,900.00 | 20 | #1 1,157.89 | 52.00 | |
142.03 | 2,536.00 | 65.41 | 262.20 | 79.10 | 23 | 307.14 | 38.56 | |
580.55 | 2,076.30 | 45.05 | 89.60 | 14.72 | 42 | 74.07 | 48.82 | |
145.54 | 1,893.20 | 38.11 | 312.50 | 136.92 | 40 | 208.70 | 50.92 | |
39.63 | 1,333.90 | 496.63 | 81.30 | 15.16 | 3 | 0.00 | 36.09 | |
34,500.00 | 1,060.40 | 9.71 | 67.60 | -16.34 | 115 | -19.54 | 41.55 |
Growth Rate
Revenue Growth
696.94 %
Net Income Growth
505.56 %
Cash Flow Change
-707.14 %
ROE
45.54 %
ROCE
79.01 %
EBITDA Margin (Avg.)
-8.84 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2025 |
| Total Assets | 1,720 |
| Fixed Assets | 0 |
| Current Assets | 1,720 |
| Capital Work in Progress | 0 |
| Investments | 0 |
| Other Assets | 1,720 |
| Total Liabilities | 1,720 |
| Current Liabilities | 1,677 |
| Non Current Liabilities | 0 |
| Total Equity | 44 |
| Reserve & Surplus | 4 |
| Share Capital | 40 |
Cash Flow
| Cash Flow | 2025 |
| Net Cash Flow | 1 |
| Investing Activities | 0 |
| Operating Activities | -1,135 |
| Financing Activities | 1,136 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Jul 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Jul 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 34.96 % | 8.43 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.11 % | 1.13 % | 1.13 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.04 % | 0.04 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 55.23 % | 83.93 % | 88.18 % | 88.55 % | 85.86 % | 86.47 % | 85.88 % | 85.87 % | 86.24 % | 86.00 % | 85.50 % | 80.87 % | 80.30 % | 82.21 % | 83.33 % | 84.50 % | 85.01 % | 86.10 % | 87.29 % | 78.39 % | 79.02 % |
| Others | 9.81 % | 7.64 % | 10.71 % | 10.34 % | 13.03 % | 12.41 % | 13.01 % | 13.02 % | 12.65 % | 12.89 % | 13.39 % | 18.02 % | 18.54 % | 16.64 % | 15.56 % | 14.39 % | 13.87 % | 12.79 % | 11.60 % | 20.48 % | 19.85 % |
| No of Share Holders | 445 | 845 | 840 | 714 | 659 | 622 | 604 | 622 | 705 | 1,730 | 2,065 | 3,988 | 3,859 | 15,587 | 26,464 | 41,565 | 67,404 | 73,637 | 1,10,422 | 1,13,543 | 1,14,119 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2020 |  Change Of Name | NA | 30 Sept 2020 | 0.20 | 0.20 |
 Bonus | 9:5 | 28 Jul 2023 | 23.44 | 0.00 | |
| 23 Jun 2023 |  Split | 5:10 | 01 Sept 2023 | 23.44 | 23.44 |
| 08 Jan 2024 | Split | 1:5 | 23 Feb 2024 | 19.58 | 19.58 |
| 26 Jun 2024 |  Annual General Meeting | NA | 26 Jun 2024 | 13.56 | 11.33 |
| 06 Jul 2024 | Bonus | 3:1 | 05 Jul 2024 | 11.33 | 14.62 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 4.69 | 4.58 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 2.80 | 2.60 |
| 15 Apr 2025 |  Rights | 61:50 | 15 Apr 2025 | 1.54 | 1.55 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 1.77 | 1.82 |
| 04 Aug 2025 | Quarterly Result Announcement | NA | 04 Aug 2025 | 1.27 | 1.31 |
| 24 Sept 2025 | Annual General Meeting | NA | 24 Sept 2025 | 1.32 | 1.50 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorOct 06, 2025
Oct 06, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 24, 2025
Sep 24, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025
Sep 24, 2025Closure of Trading WindowSep 23, 2025
Sep 23, 2025Board Meeting Outcome for Meeting Held Today 22Nd September 2025 Has Inter- Alia Considered Approved And Taken On Record 1.Change Of Name Of The Company 2. Authorised Share Capital And 3. Further Capital RaisingSep 22, 2025
Sep 22, 2025Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Meeting Of The Board Of Directors Scheduled On 22/09/2025Sep 16, 2025
Sep 16, 2025Newspaper Ad For AGM DispatchSep 06, 2025
Sep 06, 2025Reg. 34 (1) Annual Report.Sep 03, 2025
Sep 03, 2025Submission Of 36Th AGM To Be Held On Wednesday 24Th September 2025 At 11.00 A.M. Through Video Conferencing / Other Audio-Visual Means Facility (VC/OAVM).Sep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 25, 2025
Aug 25, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 13, 2025
Aug 13, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2025
Aug 11, 2025Results For The Quarter Ended June 30 2025.Aug 04, 2025
Aug 04, 2025Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2025Aug 04, 2025
Aug 04, 2025Board Meeting Intimation for Meeting Scheduled To Be Held On 04.08.2025Jul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 21, 2025
Jul 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Submission Of Newspaper For Postal Ballot NoticeJul 11, 2025
Jul 11, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJul 10, 2025
Jul 10, 2025Closure of Trading WindowJun 24, 2025
Jun 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 04, 2025
Jun 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
May 30, 2025Appointment of Company Secretary and Compliance OfficerMay 30, 2025
May 30, 2025Board Meeting Outcome for The Audited Financial Results (Standalone And Consolidated) Of The Company For The Last Quarter And Year Ended March 31 2025 And Audited Annual Accounts Of The Company The Quarter And Year Ended 31St March 2025May 30, 2025
May 30, 2025The Audited Financial Results (Standalone And Consolidated) Of The Company For The Last Quarter And Year Ended March 31 2025 And Audited Annual Accounts Of The Company For The Quarter And Year Ended 31St March 2025May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Board Meeting Intimation for Meeting Scheduled To Be Held On 30.05.2025.May 27, 2025
May 27, 2025Board Meeting Outcome for Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended.May 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 08, 2025
May 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 28, 2025
Apr 28, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 28, 2025
Apr 28, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Apr 28, 2025
Apr 28, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Apr 28, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 26, 2025
Apr 26, 2025Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Remedium Lifecare Limited Held On 24Th April 2025Apr 24, 2025
Apr 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2025
Apr 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 21, 2025
Apr 21, 2025Board Meeting Intimation for 1. To Approve The Letter Of Offer (LOF) For The Proposed Rights Issue Of 491904000 Equity Shares Of Re. 1/- Each Aggregating To 4919.04 Lakhs For Shareholders Of The Company.
2. Any Other Item With The Permission Of The ChaiApr 17, 2025
Apr 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 16, 2025
Apr 16, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 08, 2025
Apr 08, 2025Technical Indicators
RSI(14)
Neutral 58.00
ATR(14)
Less Volatile 0.09
STOCH(9,6)
Neutral 25.71
STOCH RSI(14)
Neutral 44.04
MACD(12,26)
Bearish 0.00
ADX(14)
Strong Trend 27.50
UO(9)
Bearish 35.67
ROC(12)
Uptrend And Accelerating 0.65
WillR(14)
Neutral -71.43
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
